```

[Federal Register Volume 86, Number 29 (Tuesday, February 16, 2021)]
[Notices]
[Pages 9526-9527]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03065]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration

Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Prevention's (CSAP) Drug Testing Advisory 
Board (DTAB) will convene via web conference on March 2nd, 2021, from 
10:00 a.m. EST to 4:30 p.m. EST, and March 3rd, 2021, from 10:00 a.m. 
EST to 4:30 p.m. EST.
    The board will meet in open-session March 2nd, 2021, from 10:00 
a.m. EST to 2:00 p.m. EST to discuss the Mandatory Guidelines for 
Federal Workplace Drug Testing Programs with updates from the 
Department of Transportation, the Nuclear Regulatory Commission, and 
the Department of Defense. Other discussion topics include an update on 
marijuana studies and efforts as well as the Employee Assistance 
Program (EAP) Toolkit. The board will meet in closed-session on March 
2nd, 2021, from 2:15 p.m. EST to 4:30 p.m. EST, and March 3rd, 2021, 
from 10:00 a.m. EST to 4:30 p.m. EST, to discuss confidential issues 
surrounding the proposed Mandatory Guidelines for Federal Workplace 
Drug Testing Programs (hair), the Federal Drug-Free Workplace Programs 
and emerging issues, updates on the revisions of the Urine and Oral 
Fluid Mandatory Guidelines and the Biomarker Table, preliminary and 
unpublished studies from the Johns Hopkins University Behavioral 
Pharmacology Research Unit (BPRU), and cannabidiol (CBD) information 
from FDA. Therefore, the March 2nd, 2021, from 2:15 p.m. EST to 4:30 
p.m. EST, and the March 3rd, 2021, from 10:00 a.m. EST to 4:30 p.m. 
EST, meetings are closed to the public, as determined by the Assistant 
Secretary for Mental Health and Substance Use, SAMHSA, in accordance 
with 5 U.S.C. 552b(c)(4) and

[[Page 9527]]

(9)(B), and 5 U.S.C. App. 2, Section 10(d).
    Meeting registration can be completed at http://snacregister.samhsa.gov/MeetingList.aspx. Web conference and call 
information will be sent after completing registration. Meeting 
information and a roster of DTAB members may be obtained by accessing 
the SAMHSA Advisory Committees website, https://www.samhsa.gov/about-us/advisory-councils/meetings or by contacting the Designated Federal 
Officer, Jennifer Fan.
    Committee Name: Substance Abuse and Mental Health Services 
Administration, Center for Substance Abuse Prevention, Drug Testing 
Advisory Board.
    Dates/Time/Type: March 2, 2021, from 10:00 a.m. to 2:00 p.m. EST: 
OPEN, March 2, 2021, from 2:15 p.m. to 4:30 p.m. EST: CLOSED, March 3, 
2021, from 10:00 a.m. to 4:30 p.m. EST: CLOSED.
    Place: Substance Abuse and Mental Health Services Administration, 
5600 Fishers Lane, Rockville, MD 20857.
    Contact: Jennifer Fan, Senior Pharmacist, Center for Substance 
Abuse Prevention, 5600 Fishers Lane, Room 16N06D, Rockville, Maryland 
20857, Telephone: (240) 276-1759, Email: [email protected].

    Note:  For technical reasons, SAMHSA was unable to provide the 
normal 15-day advance noticification of the meeting.

Anastasia Marie Donovan,
Policy Anayst.
[FR Doc. 2021-03065 Filed 2-12-21; 8:45 am]
BILLING CODE 4162-20-P
```